Clinical Trials Update:&nbsp;Aug. 17, 2004
4422
(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:
380219
New board will focus on safety of drugs already on the market. Also: Flarion makes bold moves to spur expansion of infrastructure for its mobile data technology.... Texas Instruments can make cheaper 3G phones.... and more.
207867
TUESDAY, Nov. 9 (HealthDayNews) -- The biggest trial to date on an experimental obesity drug shows the pill is both safe and effective, researchers say.
383170
Human Genome Sciences, Inc. announced today that it has begun dosing patients in a Phase 2 clinical trial of HGS-ETR1 (agonistic human monoclonal antibody to TRAIL Receptor 1) in patients with advanced ...
540596
TUESDAY, Dec. 18 (HealthDay News) -- A new kind of drug designed to lower levels of "bad" low-density lipoprotein (LDL) cholesterol and reduce heart disease risk has proved safe and effective in a phase II clinical trial, researchers report.
403859
TUESDAY, Oct. 5 (HealthDayNews) -- A trial for what appeared to be a promising new therapy for Parkinson's disease has been halted, although researchers haven't given up hope that the drug will one day prove useful.
69513
roundup Plus: Sun makes financial pitch...PeopleSoft-Oracle trial delayed...IBM, Boeing team up for defense work.
501426
WEDNESDAY, Aug. 18  (HealthDayNews) -- A new blood test holds promise for improving the treatment of advanced breast cancer, researchers report.
603771
roundup Plus: Shopping.com holders cut IPO shares...Transmeta starts new chip, warns on earnings...Keynote to buy researcher Vividence.
118862
roundup Plus: Hyperion targets broader base...JBoss ships J2EE app server...Firms bundle Web services wares...PMC-Sierra lowers forecast.
452626
roundup Plus: SanDisk to supply Samsung with miniSD...Hitachi unleashes 100GB notebook drives...Web services security outfits merge.
443950
October 1, 2004 5:11 PM GMT (Datamonitor) - The Food and Drug Administration (FDA) is set to examine the potential link between antidepressants and increased suicidal tendencies in adults.
641201
A preview of some of the biopharmas presenting at the American Society of Clinical Oncology conference.
306233
THURSDAY, July 5 (HealthDay News) -- New research suggests that the timing of when a woman receives the breast cancer drug Herceptin can influence its effect on her heart.
400180
Description: A new study finds that deaths in cancer drug trials have declined ten-fold, thanks to the development of drugs that are better targeted at the tumors themselves.
310131
Aventis, part of the sanofi-aventis Group (EURONEXT: SAN), announced today that The New England Journal of Medicine has published the results of two landmark phase III studies, which demonstrate that Taxotere (docetaxel) Injection Concentrate-based
117982
Robert B. Saper, MD, MPH ; Stefanos N. Kales, MD, MPH ; Janet Paquin, PhD ; Michael J. Burns, MD ; David M. Eisenberg, MD ; Roger B. Davis, ScD ; Russell S. Phillips, MD.